| RS2112808989 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112809000 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112809006 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS2112812086 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112812114 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112812135 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112812178 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112812231 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112812386 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112813757 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112813769 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112813876 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112814232 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112814246 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112814290 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112814306 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112814387 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Endometrial carcinoma |
| RS2112814388 |
SMN1
|
Health Risk |
Pathogenic |
Kugelberg-Welander disease, Kugelberg-Welander disease |
| RS2112815891 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 4, Endometrial carcinoma |
| RS2112816043 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Hereditary cancer-predisposing syndrome |
| RS2112816134 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112816143 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112819157 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112819171 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Familial adenomatous polyposis 4 |
| RS2112820022 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS2112855504 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112855544 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112857805 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112857813 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2112857873 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112866746 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112866803 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Familial adenomatous polyposis 4 |
| RS2112866857 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, MSH3-related disorder |
| RS2112868879 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112868948 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112868963 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112868967 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112879604 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112880063 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112880076 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112884291 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112884587 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112885230 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112885246 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112885348 |
MSH3
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS2112890103 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112890124 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112890201 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112890224 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2113025862 |
THG1L
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2113025865 |
IL12B
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency |
| RS2113041052 |
CYFIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2113059531 |
PROP1
|
Health Risk |
Pathogenic |
— |
| RS2113060683 |
PROP1
|
Health Risk |
Pathogenic |
— |
| RS2113064591 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS2113064700 |
PROP1
|
Health Risk |
Pathogenic |
— |
| RS2113077087 |
LSM11
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 8, Aicardi-Goutieres syndrome 8 |
| RS2113110720 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113110795 |
FOXC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113110837 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113111009 |
FOXC1
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 3, Anterior segment dysgenesis 3 |
| RS2113111101 |
FOXC1
|
Health Risk |
Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113111289 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113111322 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113111355 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113111662 |
FOXC1
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 3, Anterior segment dysgenesis 3 |
| RS2113111766 |
FOXC1
|
Health Risk |
Likely pathogenic |
Anterior segment dysgenesis 3, Anterior segment dysgenesis 3 |
| RS2113111795 |
FOXC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Axenfeld-Rieger syndrome type 3, Structural eye disease |
| RS2113112422 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113112720 |
FOXC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2113113584 |
FOXC1
|
Health Risk |
Likely pathogenic |
— |
| RS2113120213 |
SPINK5
|
Health Risk |
Pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS2113120242 |
SPINK5
|
Health Risk |
Pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS2113123881 |
F13A1
|
Health Risk |
Pathogenic |
Factor XIII, A subunit |
| RS2113154685 |
CYFIP2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 65 |
| RS2113164095 |
LCP2
|
Health Risk |
Pathogenic |
Immunodeficiency 81, Immunodeficiency 81 |
| RS2113176852 |
SGCD
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS2113177526 |
SPINK5
|
Health Risk |
Pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS2113184331 |
F13A1
|
Health Risk |
Pathogenic |
Factor XIII, A subunit |
| RS2113190301 |
ADAMTS2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2113195147 |
SPINK5
|
Health Risk |
Pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS2113199896 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2113200020 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2113200198 |
ADAMTS2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2113218754 |
ADAMTS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2113223246 |
ADAMTS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS2113228864 |
TFAP2A
|
Health Risk |
Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2113242469 |
GCM2
|
Health Risk |
Pathogenic |
Hypoparathyroidism, familial isolated |
| RS2113242520 |
GCM2
|
Health Risk |
Pathogenic |
Hypoparathyroidism, familial isolated |
| RS2113243235 |
GCM2
|
Health Risk |
Likely pathogenic |
Hyperparathyroidism 4, Hypoparathyroidism |
| RS2113257238 |
GCM2
|
Health Risk |
Likely pathogenic |
Hyperparathyroidism 4, Hyperparathyroidism 4 |
| RS2113279864 |
DOCK2
|
Health Risk |
Pathogenic |
DOCK2 deficiency, DOCK2 deficiency |
| RS2113291833 |
DOCK2
|
Health Risk |
Pathogenic |
DOCK2 deficiency, DOCK2 deficiency |
| RS2113293570 |
GABRA1
|
Health Risk |
Likely pathogenic |
Idiopathic generalized epilepsy, Epilepsy |
| RS2113298764 |
GABRG2
|
Health Risk |
Pathogenic/Likely pathogenic |
EPILEPSY, CHILDHOOD ABSENCE |
| RS2113298770 |
GABRG2
|
Health Risk |
Likely pathogenic |
EPILEPSY, CHILDHOOD ABSENCE |
| RS2113298784 |
GABRG2
|
Health Risk |
Likely pathogenic |
Febrile seizures, familial |
| RS2113301331 |
NPM1
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2113301391 |
NPM1
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS2113307162 |
GABRA1
|
Health Risk |
Likely pathogenic |
Idiopathic generalized epilepsy, Epilepsy |